Titan Pharmaceuticals, Inc. (TTNP) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 3.05M | 2.16M | 2.92M | 3.6M | 4.35M | 6.61M | 8.02M | 9.9M | 498K | 1.78M | 3.6M | 5.75M |
| Cash & Short-Term Investments | 2.8M | 1.95M | 2.83M | 3.4M | 4.09M | 6.16M | 6.76M | 8.1M | 105K | 1.14M | 2.94M | 4.45M |
| Cash Only | 2.8M | 1.95M | 2.83M | 3.4M | 4.09M | 6.16M | 6.76M | 8.1M | 105K | 1.14M | 2.94M | 4.45M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 143K | 81K | 62K | 52K | 38K | 134K | 1.05M | 1.53M | 9K | 8K | 36K | 49K |
| Days Sales Outstanding | - | - | 2.26K | - | - | - | 4.71K | 139.25K | 3.29K | 29.8 | 257.65 | 4.47K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 106K | 106K | 460K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | 899.77 | - | 180.15 |
| Other Current Assets | 105K | 130K | 30K | 151K | 220K | 318K | 212K | 277K | 384K | 535K | 524K | 276K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 35K | 68K | 100K | 314K | 383K | 455K | 529K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 35K | 68K | 100K | 133K | 335K | 407K | 481K |
| Fixed Asset Turnover | - | - | - | - | - | - | 1.19x | 0.04x | 0.01x | 0.29x | 0.13x | 0.01x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 181K | 48K | 48K | 48K |
| Total Assets | 3.05M | 2.16M | 2.92M | 3.6M | 4.35M | 6.65M | 8.09M | 10M | 812K | 2.17M | 4.06M | 6.28M |
| Asset Turnover | - | - | 0.00x | - | - | - | 0.01x | 0.00x | 0.00x | 0.05x | 0.01x | 0.00x |
| Asset Growth % | -29.86% | -67.56% | -63.85% | -63.98% | 435.71% | 206.55% | 99.26% | 59.32% | -90.24% | -78.99% | -49.24% | -34.88% |
| Total Current Liabilities | 263K | 279K | 483K | 371K | 356K | 559K | 1.44M | 1.87M | 1.85M | 2.45M | 2.63M | 2.63M |
| Accounts Payable | 219K | 194K | 202K | 371K | 356K | 371K | 348K | 407K | 597K | 567K | 695K | 812K |
| Days Payables Outstanding | - | - | - | - | - | - | 42.34K | 5.5K | 493 | 4.81K | - | 318 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 500K | 0 | 0 | 0 | 120K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 12K | 12K | 16K | 98K | 196K | 261K |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 60K | 426K | 187K | 129K | 750K |
| Current Ratio | 11.60x | 7.73x | 6.05x | 9.71x | 12.22x | 11.83x | 5.55x | 5.30x | 0.27x | 0.73x | 1.37x | 2.19x |
| Quick Ratio | 11.60x | 7.73x | 6.05x | 9.71x | 12.22x | 11.83x | 5.55x | 5.30x | 0.27x | 0.69x | 1.33x | 2.01x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | -3.88K | - | 4.33K |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 65K | 96K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 65K | 96K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 263K | 279K | 483K | 371K | 356K | 559K | 1.44M | 1.87M | 1.85M | 2.48M | 2.69M | 2.73M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 33K | 565K | 597K | 128K | 158K | 187K | 216K |
| Net Debt | -2.8M | -1.95M | -2.83M | -3.4M | -4.09M | -6.13M | -6.2M | -7.5M | 23K | -978K | -2.75M | -4.23M |
| Debt / Equity | - | - | - | - | - | 0.01x | 0.09x | 0.07x | - | - | 0.14x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | -58.52x | -187.36x | - | - | - | - |
| Total Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M | 8.13M | -1.03M | -312K | 1.36M | 3.55M |
| Equity Growth % | -30.2% | -69.16% | -63.26% | -60.27% | 486.27% | 2050.96% | 387.31% | 129.1% | -118.25% | -103.96% | -73.47% | -52.64% |
| Book Value per Share | 2.62 | 2.05 | 2.71 | 3.54 | 4.37 | 7.14 | 8.50 | 10.83 | -1.38 | -0.42 | 1.92 | 4.85 |
| Total Shareholders' Equity | 2.79M | 1.88M | 2.44M | 3.23M | 3.99M | 6.09M | 6.64M | 8.13M | -1.03M | -312K | 1.36M | 3.55M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 15K | 15K | 15K | 1K | 15K |
| Retained Earnings | -397.79M | -397.1M | -396.54M | -395.75M | -394.98M | -392.89M | -391.83M | -389.86M | -389.52M | -387.94M | -386.26M | -383.69M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |